Effect of fingolimod on circulating B cells in patients with multiple sclerosis

被引：0
|
作者：
Miyazaki, Y. [1 ]
Niino, M. [1 ]
Fukazawa, T. [2 ]
Nonaka, T. [1 ]
Amino, I. [1 ]
Tashiro, J. [1 ]
Minami, N. [1 ]
Fujiki, N. [1 ]
Doi, S. [1 ]
Kikuchi, S. [1 ]
机构：
[1] Hokkaido Med Ctr, Sapporo, Hokkaido, Japan
[2] Sapporo Neurol Clin, Sapporo, Hokkaido, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：217 / 217
页数：1
相关论文
共 50 条
  • [21] The immune-modulatory effects of fingolimod on phenotype and function of B cells from patients with Multiple Sclerosis
    Blumenfeld, Shiri
    Staun-ram, Elsebeth
    Miller, Ariel
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 214 - 214
  • [22] Fingolimod Profoundly Reduces Frequencies and Alters Subset Composition of Circulating T Follicular Helper Cells in Multiple Sclerosis Patients
    Huber, Johanna E.
    Chang, Yinshui
    Meinl, Ingrid
    Kuempfel, Tania
    Meinl, Edgar
    Baumjohann, Dirk
    JOURNAL OF IMMUNOLOGY, 2020, 204 (05): : 1101 - 1110
  • [23] Distinct modulation of circulating CD1c+conventional dendritic cells by fingolimod treatment in multiple sclerosis patients
    Luessi, F.
    Kraus, S.
    Jolivel, V.
    Hubo, M.
    Poisa-Beiro, L.
    Paterka, M.
    Siffrin, V.
    Jonuleit, H.
    Witsch, E.
    Zipp, F.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 234 - 235
  • [24] The effect of vitamin D on disease activity in multiple sclerosis patients on fingolimod
    Rotstein, D. L.
    Healy, B. C.
    Malik, M. T.
    Kivisakk, P.
    Glanz, B.
    Chitnis, T.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 158 - 158
  • [25] Fingolimod Reduces Circulating CD4+Counts in Patients with Relapsing Multiple Sclerosis (RMS)
    Smoot, Kyle
    Kresa-Reahl, Kiren
    Gaedeke, Leah
    Cohan, Stanley
    NEUROLOGY, 2012, 78
  • [26] Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis Patients
    Kowarik, M. C.
    Astling, D.
    Lepennetier, G.
    Ritchie, A.
    Hemmer, B.
    Owens, G. P.
    Bennett, Jeffrey L.
    NEUROTHERAPEUTICS, 2021, 18 (01) : 364 - 377
  • [27] Cardiac effects of fingolimod in patients with multiple sclerosis
    Hughes, B. L.
    Cascione, M.
    McCague, K.
    Pestreich, L.
    Schofield, L.
    Kim, E.
    Barbato, L. M.
    JOURNAL OF NEUROLOGY, 2013, 260 : S128 - S128
  • [28] Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis Patients
    M. C. Kowarik
    D. Astling
    G. Lepennetier
    A. Ritchie
    B. Hemmer
    G. P. Owens
    Jeffrey L. Bennett
    Neurotherapeutics, 2021, 18 : 364 - 377
  • [29] Fingolimod for Multiple Sclerosis
    Pelletier, Daniel
    Hafler, David A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04): : 339 - 347
  • [30] Fingolimod Increases Brain-Derived Neurotrophic Factor Level Secretion from Circulating T Cells of Patients with Multiple Sclerosis
    Maya Golan
    Karin Mausner-Fainberg
    Bassima Ibrahim
    Moshe Benhamou
    Adi Wilf-Yarkoni
    Hadar Kolb
    Keren Regev
    Arnon Karni
    CNS Drugs, 2019, 33 : 1229 - 1237
12345